Effects of Additional Intra-aortic Balloon Counter-Pulsation Therapy to Cardiogenic Shock Patients Supported by Extra-corporeal Membranous Oxygenation

Lian Yu Lin, Che Wei Liao, Chih Hsien Wang, Nai Hsin Chi, Hsi Yu Yu, Nai Kuan Chou, Juey Jen Hwang, Jiunn Lee Lin, Fu Tien Chiang, Yih Sharng Chen

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Extra-corporeal membranous oxygenation (ECMO) has been applied in patients with cardiopulmonary failure. One critical drawback of peripheral ECMO is an increase in left ventricular (LV) afterload which could be counterbalanced by the combination of intra-aortic balloon counter-pulsation (IABP) therapy. We hypothesized that an add-on therapy with IABP could improve outcomes in patients receiving ECMO support. We included patients (>18 years old) from 2002 to 2013 requiring ECMO support due to cardiogenic shock in a medical center. A total of 529 patients (227 ECMO alone and 302 combined IABP plus ECMO) were included. The mortality rates at 2 weeks (48.5 vs. 47.7%) after ECMO implantation were not different between the two groups (ECMO vs. combined group). After adjustment for propensity score and potential confounders, the odds ratios of outcomes within 14 days (combined group vs. ECMO) for poor LV systolic function, high preload, multi-organ failure and mortality were not different. The results remained similar for subgroup analysis. Compared with ECMO alone, combined IABP and ECMO treatment did not improve outcomes in patients with circulatory failure.

Original languageEnglish
Article number23838
JournalScientific Reports
Volume6
DOIs
Publication statusPublished - Apr 1 2016
Externally publishedYes

Fingerprint

Cardiogenic Shock
Therapeutics
Propensity Score
Mortality
Left Ventricular Function
Shock
Odds Ratio

ASJC Scopus subject areas

  • General

Cite this

Effects of Additional Intra-aortic Balloon Counter-Pulsation Therapy to Cardiogenic Shock Patients Supported by Extra-corporeal Membranous Oxygenation. / Lin, Lian Yu; Liao, Che Wei; Wang, Chih Hsien; Chi, Nai Hsin; Yu, Hsi Yu; Chou, Nai Kuan; Hwang, Juey Jen; Lin, Jiunn Lee; Chiang, Fu Tien; Chen, Yih Sharng.

In: Scientific Reports, Vol. 6, 23838, 01.04.2016.

Research output: Contribution to journalArticle

Lin, Lian Yu ; Liao, Che Wei ; Wang, Chih Hsien ; Chi, Nai Hsin ; Yu, Hsi Yu ; Chou, Nai Kuan ; Hwang, Juey Jen ; Lin, Jiunn Lee ; Chiang, Fu Tien ; Chen, Yih Sharng. / Effects of Additional Intra-aortic Balloon Counter-Pulsation Therapy to Cardiogenic Shock Patients Supported by Extra-corporeal Membranous Oxygenation. In: Scientific Reports. 2016 ; Vol. 6.
@article{0aef86e9262c47928645761f919f721c,
title = "Effects of Additional Intra-aortic Balloon Counter-Pulsation Therapy to Cardiogenic Shock Patients Supported by Extra-corporeal Membranous Oxygenation",
abstract = "Extra-corporeal membranous oxygenation (ECMO) has been applied in patients with cardiopulmonary failure. One critical drawback of peripheral ECMO is an increase in left ventricular (LV) afterload which could be counterbalanced by the combination of intra-aortic balloon counter-pulsation (IABP) therapy. We hypothesized that an add-on therapy with IABP could improve outcomes in patients receiving ECMO support. We included patients (>18 years old) from 2002 to 2013 requiring ECMO support due to cardiogenic shock in a medical center. A total of 529 patients (227 ECMO alone and 302 combined IABP plus ECMO) were included. The mortality rates at 2 weeks (48.5 vs. 47.7{\%}) after ECMO implantation were not different between the two groups (ECMO vs. combined group). After adjustment for propensity score and potential confounders, the odds ratios of outcomes within 14 days (combined group vs. ECMO) for poor LV systolic function, high preload, multi-organ failure and mortality were not different. The results remained similar for subgroup analysis. Compared with ECMO alone, combined IABP and ECMO treatment did not improve outcomes in patients with circulatory failure.",
author = "Lin, {Lian Yu} and Liao, {Che Wei} and Wang, {Chih Hsien} and Chi, {Nai Hsin} and Yu, {Hsi Yu} and Chou, {Nai Kuan} and Hwang, {Juey Jen} and Lin, {Jiunn Lee} and Chiang, {Fu Tien} and Chen, {Yih Sharng}",
year = "2016",
month = "4",
day = "1",
doi = "10.1038/srep23838",
language = "English",
volume = "6",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Effects of Additional Intra-aortic Balloon Counter-Pulsation Therapy to Cardiogenic Shock Patients Supported by Extra-corporeal Membranous Oxygenation

AU - Lin, Lian Yu

AU - Liao, Che Wei

AU - Wang, Chih Hsien

AU - Chi, Nai Hsin

AU - Yu, Hsi Yu

AU - Chou, Nai Kuan

AU - Hwang, Juey Jen

AU - Lin, Jiunn Lee

AU - Chiang, Fu Tien

AU - Chen, Yih Sharng

PY - 2016/4/1

Y1 - 2016/4/1

N2 - Extra-corporeal membranous oxygenation (ECMO) has been applied in patients with cardiopulmonary failure. One critical drawback of peripheral ECMO is an increase in left ventricular (LV) afterload which could be counterbalanced by the combination of intra-aortic balloon counter-pulsation (IABP) therapy. We hypothesized that an add-on therapy with IABP could improve outcomes in patients receiving ECMO support. We included patients (>18 years old) from 2002 to 2013 requiring ECMO support due to cardiogenic shock in a medical center. A total of 529 patients (227 ECMO alone and 302 combined IABP plus ECMO) were included. The mortality rates at 2 weeks (48.5 vs. 47.7%) after ECMO implantation were not different between the two groups (ECMO vs. combined group). After adjustment for propensity score and potential confounders, the odds ratios of outcomes within 14 days (combined group vs. ECMO) for poor LV systolic function, high preload, multi-organ failure and mortality were not different. The results remained similar for subgroup analysis. Compared with ECMO alone, combined IABP and ECMO treatment did not improve outcomes in patients with circulatory failure.

AB - Extra-corporeal membranous oxygenation (ECMO) has been applied in patients with cardiopulmonary failure. One critical drawback of peripheral ECMO is an increase in left ventricular (LV) afterload which could be counterbalanced by the combination of intra-aortic balloon counter-pulsation (IABP) therapy. We hypothesized that an add-on therapy with IABP could improve outcomes in patients receiving ECMO support. We included patients (>18 years old) from 2002 to 2013 requiring ECMO support due to cardiogenic shock in a medical center. A total of 529 patients (227 ECMO alone and 302 combined IABP plus ECMO) were included. The mortality rates at 2 weeks (48.5 vs. 47.7%) after ECMO implantation were not different between the two groups (ECMO vs. combined group). After adjustment for propensity score and potential confounders, the odds ratios of outcomes within 14 days (combined group vs. ECMO) for poor LV systolic function, high preload, multi-organ failure and mortality were not different. The results remained similar for subgroup analysis. Compared with ECMO alone, combined IABP and ECMO treatment did not improve outcomes in patients with circulatory failure.

UR - http://www.scopus.com/inward/record.url?scp=84962888121&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962888121&partnerID=8YFLogxK

U2 - 10.1038/srep23838

DO - 10.1038/srep23838

M3 - Article

C2 - 27032984

AN - SCOPUS:84962888121

VL - 6

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

M1 - 23838

ER -